You will play a central, scientific coordinating role and be involved in most of the work packages, to make sure that all the different activities are scientifically aligned and contributing towards a successful pan-EU pilot trial. In order to do this you will need to constantly bear in mind the broader goals of the project, while also contributing to more specific scientific tasks, including involvement in the analysis of process information from case studies and the subsequent recommendations on the set-up of the pan-EU pilot trial; the definition of evaluation criteria for the possible technologies for RDCT and the subsequent assessment of these technologies; international stakeholder interactions e.g. to determine the influence on ‘patient-health care provider interaction’; the development of training materials; the day-to-day project management of the pan-EU pilot work package, co-writing of the study protocol, working together with the researchers managing the execution of the trial and evaluation of the findings from the trial, as well as contributing to the final recommendations of the project.
The 5-year IMI Trials@Home project aims to reshape clinical trial design, conduct and operations by developing and piloting standards, recommendations and tools for the definition and acceptance of Remote Decentralised Clinical Trials (RDCT) in Europe. Different work packages will identify best practices for RDCT; identify and assess suitable technologies for deployment in RDCT; map the regulatory, legal and ethical framework for RDCT and determine the influence on ‘patient-health care provider interaction’ in RDCT. A pan-EU pilot trial to test the proposed approaches will be a central part of this project.
The Julius Center for Health Sciences and Primary Care is the academic coordinator for the IMI Trials@Home project. The Julius Center is one of the 11 divisions within the University Medical Center Utrecht (UMC Utrecht) and has a specific interest in Real World Evidence principles and methods. The Julius Center aspires to an international leadership role in obtaining and disseminating knowledge in the field of health sciences and primary care medicine. It has acquired a leading position by focusing on 3 pillars: ground-breaking research, successful education programs and academic primary care. The Julius Global Health group aims to build human capacity and infrastructures to improve health throughout the world. Its key outcome areas of interest are cardiovascular and maternal child health, and drugs are an essential intervention.
You have a background in epidemiology or health sciences, a PhD in a relevant area, experience in clinical (drug) trials and an interest in e-health/m-health technology/devices (experience in the use of technologies in healthcare would be an advantage). You can bear the broader goals of the project in mind, while also diving deeper into specific tasks and challenges. You must have proven writing ability, strong problem-solving and communication skills, and fluency in English. You can work independently in a multi-disciplinary team and are interested in collaborating with different partners and stakeholders locally and internationally. Good project management skills are essential.
The maximum salary for this position (67-89%) is € 5.226,00 gross per month based on full-time employment (work week 36 hours). This job is based on a temporary position for 1 year, possible extension for the duration of project.
In addition, we offer an annual benefit of 8.3%, holiday allowance, travel expenses and career opportunities. The terms of employment are in accordance with the Cao University Medical Centers (UMC).
If you have any questions about this vacancy, please contact Mrs.Mira Zuidgeest, Assistant Professor, phone number: +31 6 1133 46 98, e‑mail adress: M.G.P.Zuidgeest@umcutrecht.nl.
Acquisition based on this jobopening is not appreciated.